Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGINTERVENTIONAL

Intravesical Treatment of Bladder Cancer at Home, Multi-modal Treatment Support

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The proposed project will have two separate cohorts. The first will be to perform a more in-depth qualitative assessment of the barriers and facilitators for treatment compliance for non-muscle invasive bladder cancer. The second arm will be to create and test a BCG at home program. Participants in the second cohort will be enrolled in a conversational agent to measure patient symptoms and quality of life and improve self-efficacy.

Who May Be Eligible (Plain English)

Who May Qualify: Inclusion criteria for patients in Cohort 1 - Age 18 years or older; - completed intravesical treatment for non-muscle invasive bladder cancer within the past year Cohort 1 inclusion criteria for key stakeholders - Age 18 years or older; - experience with the delivery of BCG delivery for more than 2 years Cohort 2 inclusion criteria - Age 18 years or older; - diagnosed with non-muscle invasive bladder cancer and prescribed BCG for initial therapy Who Should NOT Join This Trial: Cohort 1 exclusion criteria • inability to provide willing to sign a consent form Cohort 2 exclusion criteria - inability to provide willing to sign a consent form - inability to undergo catheterization (i.e. - history of urethral stricture) - inability to receive BCG therapy (i.e. - previous reaction with BCG) - no access to mobile phone - inability to respond to written conversations in English Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: Inclusion criteria for patients in Cohort 1 * Age 18 years or older; * completed intravesical treatment for non-muscle invasive bladder cancer within the past year Cohort 1 inclusion criteria for key stakeholders * Age 18 years or older; * experience with the delivery of BCG delivery for more than 2 years Cohort 2 inclusion criteria * Age 18 years or older; * diagnosed with non-muscle invasive bladder cancer and prescribed BCG for initial therapy Exclusion Criteria: Cohort 1 exclusion criteria • inability to provide informed consent Cohort 2 exclusion criteria * inability to provide informed consent * inability to undergo catheterization (i.e. - history of urethral stricture) * inability to receive BCG therapy (i.e. - previous reaction with BCG) * no access to mobile phone * inability to respond to written conversations in English

Treatments Being Tested

OTHER

BCG delivery at home

The BCG at home project will be a single-arm prospective pilot, to evaluate the feasibility, scalability and effectiveness of home treatment, and utilize the BB-Bot (chatbot) for PRO and adverse event measurement.

Locations (1)

Abramson Cancer Center
Philadelphia, Pennsylvania, United States